Stereotaxis Stock
Your prediction
Stereotaxis Stock
There is an upward development for Stereotaxis compared to yesterday, with an increase of €0.022 (1.900%).
Pros and Cons of Stereotaxis in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Stereotaxis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Stereotaxis | 1.900% | -11.831% | -30.256% | -48.679% | -44.490% | -23.380% | -86.314% |
| Cardiff Oncology Inc. | 0.610% | 1.435% | -34.798% | -64.498% | -70.438% | -53.798% | -83.511% |
| Electrocore Inc. | 2.940% | 0.000% | -23.913% | -9.483% | 37.435% | 43.188% | -58.973% |
| Lightpath Techs A | 1.120% | -5.759% | -37.063% | - | 0.559% | - | - |
News
Stereotaxis Q1 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition
